Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca AbfiledCriticalAstrazeneca Ab
Publication of MY148488ApublicationCriticalpatent/MY148488A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
THE PRESENT INVENTION RELATES TO NEW COMPOUNDS OF FORMULA I, TO PHARMACEUTICAL FORMULATIONS CONTAINING THE COMPOUNDS, AND TO THE USE OF THE COMPOUNDS IN THE PREVENTION AND/OR TREATMENT OF mGluR5 RECEPTOR-MEDIATED DISORDERS.
MYPI200506062004-02-182005-02-17Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
MY148488A
(en)